These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
494 related articles for article (PubMed ID: 32249693)
1. Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-Fluorouracil and Chrysin. Khaledi S; Jafari S; Hamidi S; Molavi O; Davaran S J Biomater Sci Polym Ed; 2020 Jun; 31(9):1107-1126. PubMed ID: 32249693 [TBL] [Abstract][Full Text] [Related]
2. Upregulation of Mir-34a in AGS Gastric Cancer Cells by a PLGA-PEG-PLGA Chrysin Nano Formulation. Mohammadian F; Abhari A; Dariushnejad H; Zarghami F; Nikanfar A; Pilehvar-Soltanahmadi Y; Zarghami N Asian Pac J Cancer Prev; 2015; 16(18):8259-63. PubMed ID: 26745070 [TBL] [Abstract][Full Text] [Related]
3. PHBV/PLGA nanoparticles for enhanced delivery of 5-fluorouracil as promising treatment of colon cancer. Handali S; Moghimipour E; Rezaei M; Ramezani Z; Dorkoosh FA Pharm Dev Technol; 2020 Feb; 25(2):206-218. PubMed ID: 31648589 [TBL] [Abstract][Full Text] [Related]
4. Folic acid-decorated and PEGylated PLGA nanoparticles for improving the antitumour activity of 5-fluorouracil. El-Hammadi MM; Delgado ÁV; Melguizo C; Prados JC; Arias JL Int J Pharm; 2017 Jan; 516(1-2):61-70. PubMed ID: 27825867 [TBL] [Abstract][Full Text] [Related]
5. Physical PEGylation Enhances The Cytotoxicity Of 5-Fluorouracil-Loaded PLGA And PCL Nanoparticles. Ashour AE; Badran M; Kumar A; Hussain T; Alsarra IA; Yassin AEB Int J Nanomedicine; 2019; 14():9259-9273. PubMed ID: 31819428 [TBL] [Abstract][Full Text] [Related]
6. Di-Block PLCL and Tri-Block PLCLG Matrix Polymeric Nanoparticles Enhanced the Anticancer Activity of Loaded 5-Fluorouracil. Ashour AE; Badran MM; Kumar A; Rishi AK; Yassin AE IEEE Trans Nanobioscience; 2016 Oct; 15(7):739-747. PubMed ID: 28029617 [TBL] [Abstract][Full Text] [Related]
7. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells. Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438 [TBL] [Abstract][Full Text] [Related]
8. Enhanced antitumor efficacy in colon cancer using EGF functionalized PLGA nanoparticles loaded with 5-Fluorouracil and perfluorocarbon. Wu P; Zhou Q; Zhu H; Zhuang Y; Bao J BMC Cancer; 2020 Apr; 20(1):354. PubMed ID: 32345258 [TBL] [Abstract][Full Text] [Related]
9. Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells. Sharma A; Kaur A; Jain UK; Chandra R; Madan J Colloids Surf B Biointerfaces; 2017 Jul; 155():200-208. PubMed ID: 28431329 [TBL] [Abstract][Full Text] [Related]
10. Docetaxel-loaded PLGA and PLGA-PEG nanoparticles for intravenous application: pharmacokinetics and biodistribution profile. Rafiei P; Haddadi A Int J Nanomedicine; 2017; 12():935-947. PubMed ID: 28184163 [TBL] [Abstract][Full Text] [Related]
11. Anti-EGFR-mAb and 5-Fluorouracil Conjugated Polymeric Nanoparticles for Colorectal Cancer. Bhattacharya S Recent Pat Anticancer Drug Discov; 2021; 16(1):84-100. PubMed ID: 33349222 [TBL] [Abstract][Full Text] [Related]
12. Chondroitin sulphate decorated nanoparticulate carriers of 5-fluorouracil: development and in vitro characterization. Yadav AK; Agarwal A; Jain S; Mishra AK; Bid H; Rai G; Agrawal H; Agrawal GP J Biomed Nanotechnol; 2010 Aug; 6(4):340-50. PubMed ID: 21323107 [TBL] [Abstract][Full Text] [Related]
13. Preparation and characterization of 5-fluorouracil-loaded PLLA-PEG/PEG nanoparticles by a novel supercritical CO2 technique. Zhang C; Li G; Wang Y; Cui F; Zhang J; Huang Q Int J Pharm; 2012 Oct; 436(1-2):272-81. PubMed ID: 22721846 [TBL] [Abstract][Full Text] [Related]
14. Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery. Yu X; Hou J; Shi Y; Su C; Zhao L Int J Nanomedicine; 2016; 11():6035-6046. PubMed ID: 27881917 [TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-decorated PLGA-PEG nanoparticles for targeted delivery of SN-38 to ovarian cancer. Vangara KK; Liu JL; Palakurthi S Anticancer Res; 2013 Jun; 33(6):2425-34. PubMed ID: 23749891 [TBL] [Abstract][Full Text] [Related]
16. Biological evaluation of 5-fluorouracil nanoparticles for cancer chemotherapy and its dependence on the carrier, PLGA. Nair K L; Jagadeeshan S; Nair SA; Kumar GS Int J Nanomedicine; 2011; 6():1685-97. PubMed ID: 21980233 [TBL] [Abstract][Full Text] [Related]
17. Development of PEGylated PLGA Nanoparticles Co-Loaded with Bioactive Compounds: Potential Anticancer Effect on Breast Cancer Cell Lines. Mohammadinejad S; Jafari-Gharabaghlou D; Zarghami N Asian Pac J Cancer Prev; 2022 Dec; 23(12):4063-4072. PubMed ID: 36579986 [TBL] [Abstract][Full Text] [Related]
19. Endostar-loaded PEG-PLGA nanoparticles: in vitro and in vivo evaluation. Hu S; Zhang Y Int J Nanomedicine; 2010 Nov; 5():1039-48. PubMed ID: 21170352 [TBL] [Abstract][Full Text] [Related]
20. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Chen J; Li S; Shen Q; He H; Zhang Y Drug Dev Ind Pharm; 2011 Nov; 37(11):1339-46. PubMed ID: 21524153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]